- HealthKois launches with a $300M fund to invest in early growth-stage, tech-driven healthcare startups across India.
- The fund aims to scale impactful ventures in healthtech, life sciences, medtech, and climate health, offering $7M–$25M per investment.
In a significant development for India’s healthcare investment space, a new fund, HealthKois, has been launched with a target corpus of $300 million, along with an additional $100 million green shoe option.
Led by Charles Janssen, Ajay Mahipal, and Dr. Pinak Shrikhande, HealthKois aims to invest in early growth-stage companies that are transforming healthcare through technology and innovation.
Over the next four years, the fund plans to deploy between $7 million and $25 million per company.
HealthKois will focus on sectors such as healthtech, life sciences, medtech, healthcare delivery, and climate health, supporting startups that offer scalable, sustainable, and clinically effective solutions.
“We’re targeting companies that solve key challenges around access, affordability, and quality of care,” said Managing Partner Charles Janssen. “With access to over 75% proprietary deal flow, we’re uniquely positioned to deliver financial returns alongside meaningful social impact.”
Ajay Mahipal, Partner, emphasized HealthKois’ collaborative approach.
“We don’t just invest—we partner with founders to bring strategic support and domain expertise. It’s about scaling businesses that align performance with purpose.”
HealthKois follows the success of HealthQuad Funds I and II, which collectively reached over 90 million people and serve more than 8 million patients annually. While previous funds will continue independently, the launch of HealthKois marks a new phase in advancing inclusive healthcare solutions in India and other developing economies.
Edited by Harshajit Sarmah
